Search

everythinglearnresearchcommunity

for

Search:↓

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Tamoxifen effectively treats gynecomastia without causing impotence.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

PCOS may increase the risk of certain cancers.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Testosterone is crucial for development, growth, and various body functions in mammals.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.